CURX: curanexpharma.com Company Value to Net Income

Symbol and logo of brand Curanex Pharmaceuticals (CURX)

Curanex Pharmaceuticals Inc (CURX) minimizes risks by developing various projects to combat infections and gastrointestinal pathologies. This price chart reflects a market trend for the asset with a value of -0.60. The company relies on external CDMO contractors for drug manufacturing while maintaining R&D operations in the US. However, the narrow specialization of its development portfolio could lead to a prolonged period of unprofitability.

CURX Curanex Pharmaceuticals P/E Multiple (08/27/2025 - 11/16/2026)

Comprehensive metric breakdowns and analytics for curanexpharma.com (CURX)

- market capitalization information:
General company analysis:CURX, Curanex Pharma
Finished products of Curanex Pharmaceuticals Inc

The P/E ratio determines the multiple of market capitalization to annual net income, reflecting the degree of an asset's overvaluation or the presence of a discount relative to its fundamental value. For Curanex Pharmaceuticals Inc (CURX), whose revenues depend on the outcome of clinical trials for gastrointestinal drugs, the company's calculated P/E serves as an indicator of market expectations until stable cash flows are established.